AbbVie to buy leukemia drugmaker Pharmacyclics for $21 billion in its first deal since Shire

BING NEWS:
  • 3 Reasons to Buy AbbVie Stock on the Dip
    AbbVie's excellent dividend program remains one of the best reasons to buy the stock. Humira's patent cliff did nothing to slow things down for the drugmaker. Taking into account the time it spent ...
    05/5/2024 - 2:44 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News